Biomerics Appoints Medical Device Industry Veteran Lokram Natarajan as Senior Vice President of Quality

Biomerics has announced the appointment of Lokram Natarajan as Senior Vice President of Quality.

In this role, Natarajan will lead Biomerics’ global quality organization, supporting the company’s continued growth through operational excellence, regulatory leadership, and customer-focused quality systems that enable consistent execution across its global manufacturing operations.

Natarajan brings more than three decades of executive leadership experience across the global medical device industry. Throughout his career, he has led enterprise quality organizations, strengthened regulatory compliance, improved operational performance, and helped scale manufacturing organizations supporting some of the world’s leading medical device companies. His experience spans quality systems, operational excellence, supplier quality and organizational transformation across complex global manufacturing networks.

“At Biomerics, quality is far more than compliance; it’s one of the core foundations of the trust our customers place in us every day,” said Arun Mohan, Chief Executive Officer of Biomerics. “Lokram brings the experience, leadership and operational discipline to help us continue strengthening that trust as we grow and scale. His ability to build high-performing quality organizations while partnering closely with engineering, operations and customers makes him an outstanding addition to our executive leadership team.

“As we continue expanding our global manufacturing capabilities, maintaining world-class quality systems and operational excellence becomes even more critical. Lokram’s leadership will help ensure we continue delivering the exceptional customer experience, technical expertise and manufacturing reliability that differentiates Biomerics.”

Prior to joining Biomerics, Natarajan held executive leadership positions with leading global medical device organizations, most notably Stryker, where he was responsible for enterprise quality strategy, operational excellence, regulatory compliance and organizational transformation. He has led initiatives focused on harmonizing quality systems across multiple manufacturing sites, strengthening cross-functional collaboration, optimizing resource utilization, and creating cultures centered on continuous improvement and accountability.

“I’m excited to join Biomerics at such an important point in the company’s growth journey,” said Natarajan. “Biomerics has established itself as an industry leader by combining deep engineering expertise with advanced manufacturing capabilities and an unwavering commitment to its customers. I look forward to partnering with our talented teams around the world to further strengthen our quality systems, enhance operational performance and support our customers as they bring innovative, life-changing medical technologies to market.”

As Senior Vice President of Quality, Natarajan will lead Biomerics’ global quality organization, overseeing quality systems, regulatory compliance, supplier quality, validation and continuous improvement initiatives across the company’s global manufacturing footprint. Working closely with engineering, operations, supply chain and commercial leadership, he will help ensure quality remains a competitive advantage throughout the product development and manufacturing life cycle while supporting continued growth and operational excellence.

The appointment of Natarajan reflects Biomerics’ continued investment in experienced leadership as the company expands its global manufacturing capabilities to better serve the world’s leading medical device companies. And by strengthening its quality organization, Biomerics continues to reinforce its commitment to delivering exceptional customer experiences through manufacturing excellence and technical expertise.

Source: Biomerics

Biomerics Appoints Wil Boren to its Advisory Board

Biomerics has announced the appointment of Wil Boren to its Advisory Board.

Boren brings more than three decades of executive leadership experience across the global medical device industry, where he has successfully led large-scale manufacturing operations, operational transformations and commercial growth initiatives. As a member of Biomerics’ Advisory Board, he will provide strategic guidance to the executive leadership team as the company continues executing its long-term growth strategy.

“We’re excited to welcome Wil to the Biomerics Advisory Board,” said Arun Mohan, Chief Executive Officer. “Wil joins Jose Aguirre and Mark Benson in providing invaluable industry perspective and operational leadership. His experience building high-performing organizations, driving operational excellence and scaling complex medical device businesses aligns exceptionally well with where Biomerics is today and where we are headed.

“Our strategy remains focused on delivering an outstanding customer experience while strengthening our culture, accelerating innovation and achieving manufacturing excellence. Wil’s experience and leadership will help us continue executing on that vision.”

“I’m honored to join Biomerics’ Advisory Board during such an exciting period for the company,” said Boren. “Biomerics has built a strong reputation for innovation, technical expertise and customer partnership. I look forward to working alongside the leadership team to help support the company’s continued growth and long-term success.”

As an Advisory Board member, Boren will provide strategic counsel across operations, supply chain, commercial execution, organizational development and long-term business strategy. Working alongside the executive leadership team and fellow Advisory Board members, he will help support Biomerics’ continued focus on disciplined execution, operational excellence and sustainable growth.

Source: Biomerics

Biomerics Appoints Kristin Mason as CFO

Biomerics has announced the appointment of Kristin Mason as Chief Financial Officer.

Mason joins Biomerics following an extensive career leading finance organizations across complex global businesses. She succeeds the team of internal finance leaders who have collectively guided the finance function over the past several months.

“Kristin brings a unique combination of strategic financial leadership, operational rigor and growth experience,” said Arun Mohan, Chief Executive Officer. “Throughout her career, she has helped organizations scale, strengthen financial performance, and navigate transformational growth initiatives, including mergers and acquisitions. As Biomerics continues to expand our capabilities, global footprint, and market leadership, Kristin is the right leader to help guide our next chapter.”

“I am energized by this opportunity to lead Biomerics’ financial operations,” said Mason. “It’s exciting to join an organization filled with people who are so passionate about their mission to improve and save lives. I look forward to supporting the business as we grow our production of cutting-edge medical device components, subassemblies and finished medical devices.”

As Chief Financial Officer, Mason will provide executive leadership for Biomerics’ global finance organization, including financial planning and analysis, accounting, treasury, financial reporting, tax, audit, banking, and capital strategy. She will partner closely with the executive leadership team to strengthen financial capabilities, support disciplined execution and help position the company for continued long-term growth.

Source: Biomerics

Biomerics Appoints Arun Mohan as CEO

Biomerics has announced the appointment of Arun Mohan as Chief Executive Officer. Founder and current CEO Travis Sessions will transition into the role of Chairman of the Board, ensuring continuity in vision and strategy.

“This is a defining moment in Biomerics’ 30-year journey,” said Sessions. “Our success has always been rooted in innovation, manufacturing excellence and a relentless focus on serving our customers. Arun has the leadership, vision and proven track record to take Biomerics to the next level. With the full support of the board, I am confident that under his leadership, we will continue to deliver transformative solutions for patients while expanding our global footprint. I look forward to working alongside him as Chairman.”

“I am humbled and honored to lead Biomerics into its next chapter,” said Mohan. “Our mission is clear: to improve and save lives. To achieve this, we will place our customers at the center, invest in our people and advance manufacturing excellence as the foundation of everything we do. Together, we will innovate boldly, grow responsibly, and build a company that not only leads in medtech manufacturing, but also inspires pride in every employee and confidence in every customer.”

As CEO, Mohan will serve on the Biomerics board of directors and be responsible for the company’s global business operations, financial performance and strategic growth initiatives. He previously served as President of Biomerics’ Micro Metals Division, where he built a high-performing team that delivered exceptional results in customer satisfaction, operational efficiency and scalable growth. His leadership philosophy centers on customer centricity, employee empowerment and innovation-driven execution.

Sessions, who founded Biomerics in 1994, will remain deeply engaged as Chairman, advising Mohan on strategic initiatives, including future mergers and acquisitions. Under Sessions’s leadership, Biomerics has grown from a single-site startup to a trusted partner with over 3,000 employees across 12 locations in the United States, the Dominican Republic and Costa Rica, serving the world’s leading interventional device companies at scale.

Source: Biomerics, LLC

ThermoFab Rebrands as Innova Engineered Plastics

ThermoFab announces its new name: Innova Engineered Plastics, effective immediately. The name change reflects the company’s innovation, expanded capabilities, and focused vision as the full-service enclosure provider of choice for companies ranging from start-ups to Fortune 500 companies.

The word “Innova” is derived from innovation—a value that drives the company’s approach to design, engineer, and manufacture industry-leading enclosures. Paired with “Engineered Plastics,” it underscores the company’s deep technical expertise and engineering-driven approach to plastics manufacturing—to deliver high-quality plastic enclosure and related consumable solutions with precision, speed, and reliability.

The rebrand marks Innova’s evolution into a comprehensive plastics manufacturing partner with low-to-high volume production capabilities across multiple locations—an innovation and design center in Shirley, MA, and a high-capacity production facility in Mexicali, Mexico. Innova offers a broad suite of services such as thermoforming, injection molding, reaction injection molding (RIM), cast urethane, rapid prototyping, finishing and assembly services, and mold tool transfers—all under one roof.

“We’ve grown significantly in our capabilities, capacity, and customer base,” said Mark Rauenzahn, CEO of Innova Engineered Plastics. “Our new name better represents who we are today and where we’re headed—an innovation-driven partner delivering end-to-end plastic enclosure solutions for highly regulated industries.”

Source: ThermoFab

ThermoFab Appoints Evan Hagen as Business Development Manager

ThermoFab has announced the appointment of Evan Hagen as Business Development Manager. In this role, Mr. Hagen will drive new business development initiatives while supporting customers with timely, solution-oriented quotes—ensuring technical alignment from initial concept through full production.

Mr. Hagen brings over 10 years of engineering experience and 5 years in commercially oriented roles, combining extensive technical expertise with strong business acumen. Most recently, he served as Business Development Manager at Charter Medical, where he led commercial efforts across key strategic and growth accounts within the cell and gene therapy market. In this capacity, he managed cross-functional relationships with supply chain, engineering, and R&D teams to position high-performance single-use solutions.

His background also includes key roles in field application support, market research, and process engineering for bioprocess and medical applications. At Cook Regentec, he led cryogenic process engineering and was instrumental in launching a biologic product within a compressed 9-month timeline. Mr. Hagen has also contributed strategic insights to emerging startups through Purdue Foundry, supporting innovation commercialization efforts.

Mr. Hagen holds a Bachelor of Science in Biomedical Engineering and an MBA with a concentration in Technology Innovation and Entrepreneurship, both from Purdue University.

“We’re excited to welcome Evan Hagen to the ThermoFab team,” said Mark Rauenzahn, CEO of Producto. “Evan brings a unique combination of engineering expertise and commercial insight that aligns perfectly with our customer-focused approach and will strengthen our ability to serve customers in high-growth sectors.”

Mr. Hagen states, “I’m thrilled to join ThermoFab and contribute to its continued growth. I look forward to working with the team to expand our impact in the medical and industrial markets by building strong relationships and delivering smart, efficient solutions that meet our customers’ evolving needs.”

Source: ThermoFab 

ThermoFab Appoints Jeffrey Goble to its Advisory Board

ThermoFab has announced the appointment of Mr. Jeffrey Goble to its Board of Advisors, effective immediately. “We are delighted to welcome Jeff to the Advisory Board,” said Adam Cook, Non-Executive Chairman and Chief Investment Officer of Culper Capital Partners. “Jeff brings an exceptional track record of building and scaling global MedTech manufacturing platforms. His industry knowledge, visionary leadership, and impressive history of founding and growing successful companies in the medical device space make him a tremendous asset to ThermoFab’s continued growth. Our CEO Mark Rauenzahn, Board Member Declan Smyth (Med Device Executive) and Board Member Dean Schauer (CEO & President Confluent Medical Technologies), all are leaders with deep roots in the medical device space. I’m personally excited to see this team drive the next phase of our journey.”

Mr. Goble is a founder and current President & CEO of Arterex, a diversified global contract development and manufacturing organization serving leading MedTech OEMs and innovators. With 13 facilities across five countries and four continents, Arterex is a major player in the medical technology manufacturing space. Prior to Arterex, Mr. Goble was a founder and served as President & CEO of Providien, LLC, a diversified manufacturer of medical devices and outsourced manufacturing services for the life sciences industry, which was acquired by Carlisle Companies in 2019. He also held executive leadership positions at Medegen, Inc., where he led the company through a successful acquisition to CareFusion in 2010.

“I’m honored to join ThermoFab’s Advisory Board,” said Mr. Goble. “ThermoFab is well positioned for continued growth. I’m excited to contribute to the next phase of ThermoFab’s future alongside Adam, Declan, and the rest of the leadership team.”

Source: ThermoFab

The Producto Group Appoints Alyson Trust as Chief Financial Officer

The Producto Group has announced the appointment of Alyson Trust as Chief Financial Officer (CFO), effective immediately. In her role, Mrs. Trust will be responsible for The Producto Group’s financial strategy, budgeting, forecasting, and risk management to drive growth, optimize operations, and ensure long-term financial stability. Alyson brings over 20 years of extensive financial and operational leadership experience in both private and public sectors. She is known for optimizing financial operations, driving revenue growth, and implementing strategic financial models that provide critical insights for executive decision-making.

Prior to joining The Producto Group, Alyson served as Vice President of Finance and Acting CFO at Duchateau, where she led treasury management, risk mitigation, and financial strategy across multiple subsidiaries. She implemented robust cash flow models, streamlined budgeting and forecasting processes, and executed cost-saving initiatives that enhanced profitability and operational efficiency. Previously, as Vice President of Finance and Controller at JBT Inc., she managed financial reporting, developed 10-year capital expenditure models, and restructured corporate debt to improve financial health. Her background also includes financial analysis and business strategy roles at Accenture, where she spearheaded operational improvements for major clients.

Alyson holds an MBA with a dual emphasis in Finance and International Business from the University of San Diego and a Bachelor of Science in Finance from the University of Rhode Island. She has also completed international studies in Hong Kong, Rio de Janeiro, and Dubai, adding a global perspective to her financial expertise.

“We are excited to welcome Alyson Trust to the Producto team,” said Mark Rauenzahn, CEO of Producto. “Her extensive experience in financial strategy, operational efficiency, and risk management will be instrumental as we continue to grow and enhance our financial operations.”

Alyson shared, “I am thrilled to join The Producto Group and contribute to its ongoing success. I look forward to leveraging my experience to drive financial growth, optimize operations, and support the company’s strategic initiatives.”

Source: The Producto Group

Biomerics Expands Medical-Grade Polyurethane Offerings With Quadraflex® AREX

Biomerics has announced the addition of Quadraflex® AREX to its medical-grade polyurethane material offerings.

This new Quadraflex® product broadens Biomerics’ wide range of materials with chemistries and durometers for solution processing, complex extrusions, medical balloons and injection molding processes. Quadraflex® AREX, an aromatic polyether thermoplastic polyurethane, was developed in a key range of hardnesses to address the need for a high-quality medical-grade polymer that is available in high volumes and has a short lead time, competitive pricing and excellent technical support. This new product is ISO 10993 and USP Class VI compliant and is free of animal-derived materials. The continued development of Biomerics’ engineering Materials Center of Excellence keeps them at the forefront of contract design and manufacturing excellence in the polyurethane space.

Biomerics customizes polyurethanes and other engineered polymers for medical device applications, adding the desired colorants, radiopacifiers and other additives. Their customized polymer solutions meet the biocompatibility, biostability, durability and processing stability requirements for the most demanding catheters and interventional devices. Biomerics’ polymer chemists regularly develop and validate medical-grade polymers for a full range of highly specialized, complex interventional medical devices and components.

Kevin Grussing, President of Biomerics’ Plastics Division, says, “Our Quadra™ family of medical polyurethanes is a valuable element of our performance materials manufacturing capabilities. Investing in innovative, customizable solutions like this that are readily available at high volumes enables us to better serve our global customers. The Quadraflex® AREX product addition reflects our ongoing commitment to providing best-in-class polyurethane solutions that meet the evolving design and manufacturing needs of our partners.”

Source: Biomerics